Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology November 1, 2020 Natasha L. Mason, K P C Kuypers, F Müller et al. 261 citations
There is growing interest in the therapeutic utility of psychedelic substances, like psilocybin, for disorders characterized by distortions of the self-experience, like depression. Accumulating preclinical evidence emphasizes the role of the glutamate system in the acute action of the drug on brain and behavior; however this has never been tested in humans. Following a double-blind,...